Bone Marrow TransplantationTransplantation, HomologousGraft vs Host DiseaseBone MarrowTransplantation, AutologousWhole-Body IrradiationBone Marrow CellsTransplantation ConditioningLeukemiaAnemia, AplasticHematopoietic Stem Cell TransplantationTransplantation ChimeraTissue DonorsBusulfanGraft SurvivalLeukemia, Myelogenous, Chronic, BCR-ABL PositiveLiver TransplantationHistocompatibility TestingRecurrenceLeukocyte TransfusionGraft vs Tumor EffectHistocompatibilityCyclophosphamideHematologic NeoplasmsRemission InductionLeukemia, Myeloid, AcuteRadiation ChimeraTransplantation, IsogeneicPrecursor Cell Lymphoblastic Leukemia-LymphomaGraft vs Host ReactionLymphocyte DepletionGraft vs Leukemia EffectImmunosuppressive AgentsKidney TransplantationAcute DiseaseLymphocyte TransfusionCombined Modality TherapyGraft RejectionTreatment OutcomeHepatic Veno-Occlusive DiseaseBone Marrow PurgingImmunosuppressionBone and BonesTransplantation ImmunologyLeukemia, MyeloidHematopoietic Stem CellsMice, Inbred C57BLTime FactorsT-LymphocytesChimeraMyelodysplastic SyndromesCyclosporineHematopoiesisStem Cell TransplantationNuclear FamilySurvival AnalysisRetrospective StudiesHeart TransplantationActuarial AnalysisHLA AntigensCytomegalovirus InfectionsLymphoma, Non-HodgkinHematologic DiseasesLung TransplantationFatal OutcomeMice, Inbred BALB CSurvival RateCytarabineSevere Combined ImmunodeficiencyFollow-Up StudiesAntineoplastic Combined Chemotherapy ProtocolsDisease-Free SurvivalBone Marrow DiseasesGranulocyte Colony-Stimulating FactorOrgan TransplantationSpleenLeukocyte CountMultiple MyelomaPancytopeniaEtoposideInfectionLymphomaSkin TransplantationLeukemia, Myelomonocytic, AcuteAnemia, Refractory, with Excess of BlastsAntilymphocyte SerumMethotrexatePrognosisNeoplasm, ResidualFlow CytometryPeripheral Blood Stem Cell TransplantationBone Marrow ExaminationCell TransplantationCyclosporinsSalvage TherapyTransplantation ToleranceImmunocompromised HostIslets of Langerhans TransplantationLymphocyte Culture Test, MixedLymphocyte Activation